NeuroOne Medical Technologies Corporation (NMTC)
(Delayed Data from NSDQ)
$0.93 USD
+0.03 (3.33%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $0.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
NMTC 0.93 +0.03(3.33%)
Will NMTC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NMTC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NMTC
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment
NMTC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NMTC
Is NMTC showing upside potential? Stochastic Buy Signal shows up after gaining 3.33%
NMTC forms 180 Bullish Setup on October 2
20 Day Moving Average Support appears for NMTC after 0.07% move
Is NMTC positioned for a breakout? 20 Day Moving Average Support shows up after sliding 1.27%
NMTC's price falls by 2.07% on September 29, though its technical setup remains stable.